logo
Select company
Select metric
$ 4.88Free Cash Flow per Share
VS
Market
84
Sector
93
Industry
99
History
100
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information

Ticker

TBPH

Company Name

THERAVANCE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

THERAVANCE BIOPHARMA INC - Free Cash Flow per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TBPH - FCFPS Historical data
DateFree Cash FlowFree Cash Flow per ShareShare FactorWeighted Average Shares
6/30/2025$ 244.78M$ 4.88150.18M
3/31/2025$ 32.28M$ 0.65149.71M
12/31/2024$ -11.87M$ -0.24148.85M
9/30/2024$ -12.31M$ -0.25149.04M
6/30/2024$ -9.6M$ -0.2148.75M
3/31/2024$ -17.14M$ -0.35148.28M
12/31/2023$ -27.97M$ -0.51155.3M
9/30/2023$ -150.76M$ -2.88152.36M
6/30/2023$ -170.34M$ -3.01156.68M
3/31/2023$ -173.18M$ -2.75162.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) FCFPS stands at $ -4.05.
  • Over the past 5 years, THERAVANCE BIOPHARMA INC's average FCFPS has been $ -1.76.
  • The median FCFPS for THERAVANCE BIOPHARMA INC during this period was $ -2.35
  • THERAVANCE BIOPHARMA INC reached its highest FCFPS over the past 5 years at $ 4.88.
  • The lowest FCFPS recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ -4.23

THERAVANCE BIOPHARMA INC's FCFPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCFPS Benchmarks
CompanyFCFPS
SAGE : SAGE THERAPEUTICS INC $ -4.62KURA : KURA ONCOLOGY INC $ 1.4ZVRA : ZEVRA THERAPEUTICS INC $ -0.85NKTR : NEKTAR THERAPEUTICS $ -8.57GYRE : GYRE THERAPEUTICS INC $ 0NRIX : NURIX THERAPEUTICS INC $ -2.87EYPT : EYEPOINT PHARMACEUTICALS INC $ -2.77SNDX : SYNDAX PHARMACEUTICALS INC $ -3.51ADCT : ADC THERAPEUTICS SA $ -1.12YMAB : Y-MABS THERAPEUTICS INC $ -0.4

Similar metrics to Shares WA:

Definition of Free Cash Flow per Share

[Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
FCF / (Shares WA * Share Factor)
(=) FCFPS FCFPS for THERAVANCE BIOPHARMA INC is calculated as follows: FCF [ $ -256.47M ] / (Shares WA [ 63.3M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -4.05 ]

TBPH - Free Cash Flow per Share, Last 5 years

$ -4.23

Minimum

Mar 31, 2021

$ 4.88

Maximum

Jun 30, 2025

$ -1.76

Average

$ -2.35

Median

FCFPS Benchmark Analysis

 The chart above depicts the distribution of FCFPS for companies in the Total Stock Market. The average FCFPS of the companies is $ 0.8 with a standard deviation of $ 2.82.
The following table provides additional summary stats:
FCFPS in the Market:
filtered constituents3.76K
min$ -7.96
max$ 8.85
average$ 0.8
median$ 0.29
std$ 2.82